Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CLXT

Calyxt (CLXT) Stock Price, News & Analysis

Calyxt logo

About Calyxt Stock (NASDAQ:CLXT)

Advanced Chart

Key Stats

Today's Range
$6.01
$7.77
50-Day Range
$6.30
$31.50
52-Week Range
$1.25
$7.77
Volume
254,056 shs
Average Volume
139,308 shs
Market Capitalization
$31.31 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CLXT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Calyxt and its competitors with MarketBeat's FREE daily newsletter.

CLXT Stock News Headlines

Silicon Valley Gold Rush
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.
Calyxt Completes One-for-Ten Reverse Stock Split
Calyxt Announces Effective Date of Reverse Stock Split
See More Headlines

CLXT Stock Analysis - Frequently Asked Questions

Calyxt, Inc. (NASDAQ:CLXT) released its quarterly earnings data on Monday, May, 1st. The company reported ($5.45) earnings per share (EPS) for the quarter, missing the consensus estimate of ($3.00) by $2.45. The business earned $0.04 million during the quarter. Calyxt had a negative net margin of 9,979.64% and a negative trailing twelve-month return on equity of 259.69%.

Shares of Calyxt reverse split on Thursday, June 1st 2023.The 1-5 reverse split was announced on Thursday, June 1st 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, June 1st 2023. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split.

Calyxt (CLXT) raised $101 million in an IPO on Thursday, July 20th 2017. The company issued 6,100,000 shares at $15.00-$18.00 per share. Citigroup, Credit Suisse, JefferiesWells and Fargo Securities served as the underwriters for the IPO and BMO Capital Markets and Ladenburg Thalmann were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Calyxt investors own include Cellectis (CLLS), Intel (INTC), Plug Power (PLUG), First Solar (FSLR), Intellia Therapeutics (NTLA), NVIDIA (NVDA) and Sorrento Therapeutics (SRNE).

Company Calendar

Last Earnings
5/01/2023
Today
7/04/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:CLXT
Fax
N/A
Employees
48
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$16.89 million
Net Margins
-9,979.64%
Pretax Margin
-9,979.64%

Debt

Sales & Book Value

Annual Sales
$160 thousand
Price / Cash Flow
N/A
Book Value
$0.54 per share
Price / Book
11.67

Miscellaneous

Free Float
4,865,000
Market Cap
$31.31 million
Optionable
Not Optionable
Beta
1.98

Social Links

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:CLXT) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners